Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis.

Saved in:
Bibliographic Details
Title: Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis.
Authors: Baeza-Raja B; Second Genome Inc., South San Francisco, California, United States of America., Goodyear A; Second Genome Inc., South San Francisco, California, United States of America., Liu X; Department of Surgery, University of California San Diego, La Jolla, California, United States of America., Lam K; Department of Surgery, University of California San Diego, La Jolla, California, United States of America., Yamamoto L; Second Genome Inc., South San Francisco, California, United States of America., Li Y; Second Genome Inc., South San Francisco, California, United States of America., Dodson GS; Second Genome Inc., South San Francisco, California, United States of America., Takeuchi T; Second Genome Inc., South San Francisco, California, United States of America., Kisseleva T; Department of Surgery, University of California San Diego, La Jolla, California, United States of America., Brenner DA; Department of Medicine, University of California San Diego, La Jolla, California, United States of America., Dabbagh K; Second Genome Inc., South San Francisco, California, United States of America.
Source: PloS one [PLoS One] 2020 Jun 03; Vol. 15 (6), pp. e0234038. Date of Electronic Publication: 2020 Jun 03 (Print Publication: 2020).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first